SITC 2018, couple of weeks away kids, Victoria Atkinson, lead author...
I'm more than quite confident she has something positive to spruick otherwise,
yes otherwise, what's the point of her being the lead....For those unaware,
Victoria is at the Greenslopes Hospital where tacti-mel trials commenced and
not directly employed by Immutep.......Just remember though, it's still PH1 which
is largely a precursor to formulating PH2 trials being commenced with acceptable
dosages etc........
Ann: Immutep to present at SITC 2018, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.020(6.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $1.905M | 6.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13147 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 101130 | 2 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
